Industry Voice: BMO's latest engagement - a focus on social issues

Historically difficult for investors to define and quantify, social issues are now among the most pressing issues for companies globally – discover our engagement on some of these issues, including antimicrobial resistance in Q4 2020.

clock • 2 min read
Industry Voice: BMO's latest engagement - a focus on social issues

Raising awareness on antimicrobial resistance (AMR)

Engagement progress update

Antimicrobial Resistance (AMR) is a natural phenomenon in which microorganisms develop resistance to antimicrobial agents. However, it is being accelerated by poor stewardship of antibiotics in healthcare and farming: antimicrobial-resistant microbes can spread between people and animals, and from person to person. As a result, a growing number of common bacterial infections - from pneumonia to urinary tract infections - are becoming more difficult to treat. If antibiotics continue to lose their effectiveness, caesarean sections and chemotherapy, as well as other commonplace medical interventions, could become extremely high risk and severely undermine modern medicine.

 

Continue Reading

 

Disclaimers:

The value of investments and any income derived from them can go down as well as up as a result of market or currency movements and investors may not get back the original amount invested. Views and opinions have been arrived at by BMO Global Asset Management and should not be considered to be a recommendation or solicitation to buy or sell any stocks or products that may be mentioned.  

©2021 BMO Global Asset Management. BMO Global Asset Management is a registered trading name for various affiliated entities of BMO Global Asset Management (EMEA) that provide investment management services, institutional client services and securities products. Financial promotions are issued for marketing and information purposes; in the United Kingdom by BMO Asset Management Limited, which is authorised and regulated by the Financial Conduct Authority; in the EU by BMO Asset Management Netherlands B.V., which is regulated by the Dutch Authority for the Financial Markets (AFM); and in Switzerland by BMO Global Asset Management (Swiss) GmbH, acting as representative office of BMO Asset Management Limited. These entities are all wholly owned subsidiaries of Columbia Threadneedle Investments UK International Limited, whose direct parent is Ameriprise Inc., a company incorporated in the United States. They were formerly part of BMO Financial Group and are currently using the "BMO" mark under licence.

More on ESG

Credit: Karwai Tang/UK government
ESG

Asset management industry sees silver lining in watered down COP26 deal

Investors should see opportunities

Pedro Gonçalves
clock 26 November 2021 • 4 min read
Don't take corporate net zero pledges at face value
ESG

Don't take corporate net zero pledges at face value

Very few companies on track to meet targets

Dan Lefkovitz and Alex Osborne-Saponja
clock 25 November 2021 • 4 min read
Unlocking asset owner capital crucial to net zero goals
ESG

$23trn held by top 100 asset owners 'key' to achieving net zero goals

14 out of top 100 asset owners aligned with net zero, according to TAI research

clock 25 November 2021 • 2 min read